Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1CNS 1

Conditions

Influenza, Human 16Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Multiple Myeloma 4Lymphoma 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Lymphoma, Non-Hodgkin 3Leukemia 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Virus Diseases 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 153Dexamethasone 141Rituximab 85fludarabine 79Lenalidomide 72Cytarabine 70Bortezomib 64fludarabine phosphate 63Gemcitabine 62venetoclax 54Etoposide 53pomalidomide 52pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Influenza Vaccines × Clear all
NCT07502287 2026-03-30

DUAL-NK-NB

Beijing Biotech

Phase 1/2 Recruiting
36 enrolled
CNS

Neuroblastoma, Recurrence, Ganglioneuroblastoma

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Hebei Senlang Biotechnology Inc., Ltd.

Phase EARLY_PHASE1 Unknown
50 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡